In vitro fibrillization of Alzheimer’s amyloid-β peptide (1-42)
Source abstract
Abstract
The amyloid deposition in the form of extracellular fibrillar aggregates of amyloid-β (Aβ) peptide is a critical pathological event in Alzheimer’s disease. Here, we report a systematic investigation of the effects of environmental factors on the kinetics of Aβ fibrillization in vitro. The effects of Aβ42 peptide concentration, temperature, pH, added solvents and the ratio of Aβ40 and Aβ42 on the peptide fibrillization under agitated conditions was studied. The analysis show that the rate of fibril growth by monomer addition is not limited by diffusion but by rearrangement in the monomer structure, which is enhanced by low concentrations of fluorinated alcohols and characterized by the activation energy of 12 kcal/mol. Fibrillization rate decreases at pH values below 7.0 where simultaneous protonation of His 13 and 14 inhibits fibril formation. The lag period for Aβ42 was only twofold shorter and the fibril growth rate twofold faster than those of Aβ40. Lag period was shortened and the fibrillization rate was increased only at 90% content of Aβ42.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Alzheimer's disease research and treatments · Cholinesterase and Neurodegenerative Diseases · Computational Drug Discovery Methods
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Tallinn University of Technology 1 Department of Gene Technology, , Tallinn 12618, Estonia
Stockholm University 2 Department of Biochemistry and Biophysics, Arrhenius Laboratories, , Stockholm, 106 91, Sweden
References (40)
Show source-provided references
1. Alternative conformations of amyloidogenic proteins govern their behavior10.1016/S0959-440X(96)80089-3 ↗
2. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants10.1073/pnas.93.3.1125 ↗
3. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie?10.1016/0092-8674(93)90635-4 ↗
4. An Analytical Solution to the Kinetics of Breakable Filament Assembly10.1126/science.1178250 ↗
5. Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue10.1016/j.cell.2013.08.035 ↗
6. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases10.1038/nature12481 ↗
7. Effect of agitation on the peptide fibrillization: Alzheimer’s amyloid-beta peptide 1-42 but not amylin and insulin fibrils can grow under quiescent conditions10.1002/psc.2513 ↗
8. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis10.1074/jbc.M210207200 ↗
9. Agitation of amyloid proteins to speed aggregation measured by ThT fluorescence: A call for standardization10.1016/j.msec.2014.09.015 ↗
10. Monitoring of amyloid-beta fibrillization using an improved fluorimetric method
11. Label-free high-throughput screening assay for inhibitors of Alzheimer’s amyloid-beta peptide aggregation based on MALDI MS10.1021/ac101583q ↗
12. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds10.1111/j.1742-4658.2009.07307.x ↗
13. Probing the mechanism of insulin fibril formation with insulin mutants10.1021/bi0105983 ↗
14. Fibrillation precursor of superoxide dismutase 1 revealed by gradual tuning of the protein-folding equilibrium10.1073/pnas.1201795109 ↗
15. Amyloid β-Protein Aggregation Produces Highly Reproducible Kinetic Data and Occurs by a Two-Phase Process10.1021/cn900015v ↗
16. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators10.1111/j.1471-4159.2009.06269.x ↗
17. Energy landscape theory for Alzheimer’s amyloid beta-peptide fibril elongation10.1002/1097-0134(20010201)42:2%3C217::AID-PROT90%3E3.0.CO;2-N ↗
18. Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways10.1073/pnas.222681699 ↗
19. Probing the efficacy of peptide-based inhibitors against acid- and zinc-promoted oligomerization of amyloid-beta peptide via single-oligomer spectroscopy10.1016/j.bpc.2011.08.006 ↗
20. Physiochemical characterization of the Alzheimer’s disease-related peptides A beta 1-42Arctic and A beta 1-42wt10.1111/j.1742-4658.2006.05263.x ↗
21. Investigation of the Mechanism of beta-Amyloid Fibril Formation by Kinetic and Thermodynamic Analyses10.1021/la703369b ↗
22. Protofibril formation of amyloid beta-protein at low pH via a non-cooperative elongation mechanism10.1074/jbc.M500052200 ↗
23. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability10.1074/jbc.M201750200 ↗
24. Alzheimer’s disease amyloid propagation by a template-dependent dock-lock mechanism10.1021/bi992933h ↗
25. Temperature-dependent beta-sheet formation in beta-amyloid Abeta(1-40) peptide in water: uncoupling beta-structure folding from aggregation10.1016/S0167-4838(99)00228-9 ↗
26. Kinetic theory of amyloid fibril templating10.1063/1.4803658 ↗
27. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition10.1126/science.1853202 ↗
28. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer’s disease10.1006/jmbi.1998.2348 ↗
29. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization10.1074/jbc.M204168200 ↗
30. The effect of A beta conformation on the metal affinity and aggregation mechanism studied by circular dichroism spectroscopy10.1093/jb/mvj083 ↗
31. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation10.1021/ja036813f ↗
32. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer’s disease10.1006/abbi.1993.1112 ↗
33. Co-incorporation of A beta 40 and A beta 42 to form mixed pre-fibrillar aggregates10.1046/j.1432-1033.2003.03415.x ↗
34. Alzheimer’s Abeta42 and Abeta40 peptides form interlaced amyloid fibrils
35. Abeta40 Protects Non-toxic Abeta42 Monomer from Aggregation10.1016/j.jmb.2007.04.014 ↗
36. The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity10.1074/jbc.M803159200 ↗
37. Abeta40 inhibits amyloid deposition in vivo10.1523/JNEUROSCI.4849-06.2007 ↗
38. Urea modulation of beta-amyloid fibril growth: experimental studies and kinetic models10.1110/ps.04847404 ↗
39. Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation10.1038/nchembio.1750 ↗
40. The missing link in the amyloid cascade of Alzheimer’s disease – Metal ions10.1016/j.neuint.2013.01.023 ↗